Literature DB >> 1723000

Enzymatic degradation and immunogenic properties of derivatized dextrans.

B Crepon1, J Jozefonvicz, V Chytry, B Rihová, J Kopecek.   

Abstract

Dextran T40 was modified with carboxylic, benzylamide and benzylamine-sulphonated groups (samples 1-10). The polymers were incubated with dextranase and the decrease of molecular weight was determined by high performance size exclusion chromatography. It was shown that the higher the substitution of dextrans, the lower their degradability. Modification of dextran with benzylamine and benzylamine-sulphonated groups appeared to hinder the formation of the enzyme-substrate complex more than the same quantity of carboxylic groups. The immunogenicity of one of the modified dextrans, containing 54% of carboxylic groups and 19.5% of benzylamine-sulphonated groups, was determined after subcutaneous and intravenous administration into Balb/c mice. The antibody titre was very low even if administered in complete Freund's adjuvant and did not depend on the injected dose. On the average, the titres of antibodies were lower by five orders of magnitude compared to bovine gamma globulin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723000     DOI: 10.1016/0142-9612(91)90049-g

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

1.  Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics.

Authors:  Jessica L Cohen; Stephanie Schubert; Peter R Wich; Lina Cui; Joel A Cohen; Justin L Mynar; Jean M J Fréchet
Journal:  Bioconjug Chem       Date:  2011-05-24       Impact factor: 4.774

2.  Synthesis of temperature-responsive dextran-MA/PNIPAAm particles for controlled drug delivery using superhydrophobic surfaces.

Authors:  Ana Catarina Lima; Wenlong Song; Barbara Blanco-Fernandez; Carmen Alvarez-Lorenzo; João F Mano
Journal:  Pharm Res       Date:  2011-02-05       Impact factor: 4.200

Review 3.  Microbial dextran-hydrolyzing enzymes: fundamentals and applications.

Authors:  Elvira Khalikova; Petri Susi; Timo Korpela
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

4.  Anti-MicroRNA-21 Oligonucleotide Loaded Spermine-Modified Acetalated Dextran Nanoparticles for B1 Receptor-Targeted Gene Therapy and Antiangiogenesis Therapy.

Authors:  Tao Zheng; Wentao Wang; Mohsen Mohammadniaei; Jon Ashley; Ming Zhang; Ninglin Zhou; Jian Shen; Yi Sun
Journal:  Adv Sci (Weinh)       Date:  2021-12-22       Impact factor: 16.806

Review 5.  Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.

Authors:  Zheng-Rong Lu; Aaron M Mohs; Yuda Zong; Yi Feng
Journal:  Int J Nanomedicine       Date:  2006
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.